Flupentixol-t-melitracen tablet, a new antidepressant drug of HISCO, was first imitated in the field
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the website of the State Food and Drug Administration (CFDA) on May 21, Flupentixol tablets, a 6-class antidepressant drug of Hisilicon, entered the site for examination this month and are expected to be the top in China Flupentixicine tablet is an anti anxiety psychoactive drug It mainly treats neurasthenia, psychogenic depression, depressive neurosis, hidden depression, psychosomatic diseases with anxiety and apathy, menopausal depression, alcoholism and drug addicts' restlessness and depression The product name of flupentixomil tablets is "delixin", and the original manufacturer is Denmark Lingbei Pharmaceutical Co., Ltd at present, only the original research drugs are sold in China, including Enhua Pharmaceutical Co., Ltd and Hainan Yier Pharmaceutical Co., Ltd which are in the state of "under review" Hisic has been leading other enterprises, taking the lead in on-site inspection Hisico is the leader in the field of parenteral nutrition medicine, characteristic anti infection medicine and hepatobiliary disease medicine In the prospectus, the company has said that it will focus on tracking the development trend of innovative generic drugs in the international mainstream market, and establish the domestic leading new drug variety reserve resources The Research Report of Guolian securities also points out that as one of the heavyweight new drugs with huge potential, droperidol tablets are expected to be approved for production in 2014.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
